Vice President Christian Frois Discusses Strategies to Establish the Value of Immuno-Oncology Therapies in the European Health Care Market
Event:Immunotherapy Europe 2016
Dates:September 21–22, 2016
Dr. Frois will chair the plenary session of this two-day conference, which addresses the adoption of novel European pricing and reimbursement models in an evolving oncology health care marketplace. In addition, Dr. Frois will present “Establishing the Value of Immuno-Oncology Therapies to Payers and HTAs – What are the Implications for Pricing and Evidence Generation?” Analysis Group is sponsoring the event.
View additional information
Associated Experts & Staff